189 related articles for article (PubMed ID: 29945023)
1. Selective Cu(I) complex with phosphine-peptide (SarGly) conjugate contra breast cancer: Synthesis, spectroscopic characterization and insight into cytotoxic action.
Komarnicka UK; Kozieł S; Starosta R; Kyzioł A
J Inorg Biochem; 2018 Sep; 186():162-175. PubMed ID: 29945023
[TBL] [Abstract][Full Text] [Related]
2. Copper(I) complexes with phosphines P(p-OCH
Komarnicka UK; Kozieł S; Zabierowski P; Kruszyński R; Lesiów MK; Tisato F; Porchia M; Kyzioł A
J Inorg Biochem; 2020 Feb; 203():110926. PubMed ID: 31759264
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of anticancer activity in vitro of a stable copper(I) complex with phosphine-peptide conjugate.
Komarnicka UK; Pucelik B; Wojtala D; Lesiów MK; Stochel G; Kyzioł A
Sci Rep; 2021 Dec; 11(1):23943. PubMed ID: 34907288
[TBL] [Abstract][Full Text] [Related]
4. Copper(i) complexes with phosphine derived from sparfloxacin. Part III: multifaceted cell death and preliminary study of liposomal formulation of selected copper(i) complexes.
Kyzioł A; Cierniak A; Gubernator J; Markowski A; Jeżowska-Bojczuk M; Komarnicka UK
Dalton Trans; 2018 Feb; 47(6):1981-1992. PubMed ID: 29345262
[TBL] [Abstract][Full Text] [Related]
5. Copper(I)-Phosphine Polypyridyl Complexes: Synthesis, Characterization, DNA/HSA Binding Study, and Antiproliferative Activity.
Villarreal W; Colina-Vegas L; Visbal G; Corona O; Corrêa RS; Ellena J; Cominetti MR; Batista AA; Navarro M
Inorg Chem; 2017 Apr; 56(7):3781-3793. PubMed ID: 28290674
[TBL] [Abstract][Full Text] [Related]
6. Cu
Bykowska A; Komarnicka UK; Jeżowska-Bojczuk M; Kyzioł A
J Inorg Biochem; 2018 Apr; 181():1-10. PubMed ID: 29348049
[TBL] [Abstract][Full Text] [Related]
7. Copper(i) complexes with phosphine derived from sparfloxacin. Part I - structures, spectroscopic properties and cytotoxicity.
Komarnicka UK; Starosta R; Kyzioł A; Jeżowska-Bojczuk M
Dalton Trans; 2015 Jul; 44(28):12688-99. PubMed ID: 26085118
[TBL] [Abstract][Full Text] [Related]
8. Anticancer activity of a new copper(II) complex with a hydrazone ligand. Structural and spectroscopic characterization, computational simulations and cell mechanistic studies on 2D and 3D breast cancer cell models.
Balsa LM; Ferraresi-Curotto V; Lavecchia MJ; Echeverría GA; Piro OE; García-Tojal J; Pis-Diez R; González-Baró AC; León IE
Dalton Trans; 2021 Jul; 50(28):9812-9826. PubMed ID: 34190268
[TBL] [Abstract][Full Text] [Related]
9. New copper(I) complexes bearing lomefloxacin motif: Spectroscopic properties, in vitro cytotoxicity and interactions with DNA and human serum albumin.
Komarnicka UK; Starosta R; Kyzioł A; Płotek M; Puchalska M; Jeżowska-Bojczuk M
J Inorg Biochem; 2016 Dec; 165():25-35. PubMed ID: 27764707
[TBL] [Abstract][Full Text] [Related]
10. Cu(I) complexes as new antiproliferative agents against sensitive and doxorubicin resistant colorectal cancer cells: synthesis, characterization, and mechanisms of action.
Sequeira D; Baptista PV; Valente R; Piedade MFM; Garcia MH; Morais TS; Fernandes AR
Dalton Trans; 2021 Feb; 50(5):1845-1865. PubMed ID: 33470993
[TBL] [Abstract][Full Text] [Related]
11. Selective anticancer copper(II)-mixed ligand complexes: targeting of ROS and proteasomes.
Ng CH; Kong SM; Tiong YL; Maah MJ; Sukram N; Ahmad M; Khoo AS
Metallomics; 2014 Apr; 6(4):892-906. PubMed ID: 24549332
[TBL] [Abstract][Full Text] [Related]
12. Neutral and charged phosphine/scorpionate copper(I) complexes: effects of ligand assembly on their antiproliferative activity.
Porchia M; Dolmella A; Gandin V; Marzano C; Pellei M; Peruzzo V; Refosco F; Santini C; Tisato F
Eur J Med Chem; 2013 Jan; 59():218-26. PubMed ID: 23229057
[TBL] [Abstract][Full Text] [Related]
13. Copper(I) complexes with phosphine derived from sparfloxacin. Part II: a first insight into the cytotoxic action mode.
Komarnicka UK; Starosta R; Płotek M; de Almeida RF; Jeżowska-Bojczuk M; Kyzioł A
Dalton Trans; 2016 Mar; 45(12):5052-63. PubMed ID: 26674970
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological characterization and evaluation of molecular mechanisms of novel copper complexes as anticancer agents.
Acilan C; Cevatemre B; Adiguzel Z; Karakas D; Ulukaya E; Ribeiro N; Correia I; Pessoa JC
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):218-234. PubMed ID: 27773706
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, structures and anticancer potentials of platinum(II) saccharinate complexes of tertiary phosphines with phenyl and cyclohexyl groups targeting mitochondria and DNA.
Yilmaz VT; Icsel C; Turgut OR; Aygun M; Erkisa M; Turkdemir MH; Ulukaya E
Eur J Med Chem; 2018 Jul; 155():609-622. PubMed ID: 29920455
[TBL] [Abstract][Full Text] [Related]
16. Luminescent Cycloplatinated Complexes with Biologically Relevant Phosphine Ligands: Optical and Cytotoxic Properties.
Millán G; Giménez N; Lara R; Berenguer JR; Moreno MT; Lalinde E; Alfaro-Arnedo E; López IP; Piñeiro-Hermida S; Pichel JG
Inorg Chem; 2019 Jan; 58(2):1657-1673. PubMed ID: 30601653
[TBL] [Abstract][Full Text] [Related]
17. Vanadium(IV) and copper(II) complexes of salicylaldimines and aromatic heterocycles: Cytotoxicity, DNA binding and DNA cleavage properties.
Correia I; Roy S; Matos CP; Borovic S; Butenko N; Cavaco I; Marques F; Lorenzo J; Rodríguez A; Moreno V; Pessoa JC
J Inorg Biochem; 2015 Jun; 147():134-46. PubMed ID: 25858461
[TBL] [Abstract][Full Text] [Related]
18. Effects of the tetravanadate [V
Sánchez-Lara E; Favela R; Tzian K; Monroy-Torres B; Romo-Pérez A; Ramírez-Apan MT; Flores-Alamo M; Rodríguez-Diéguez A; Cepeda J; Castillo I
J Biol Inorg Chem; 2024 Feb; 29(1):139-158. PubMed ID: 38175299
[TBL] [Abstract][Full Text] [Related]
19. Novel silver glycinate conjugate with 3D polymeric intermolecular self-assembly architecture; an antiproliferative agent which induces apoptosis on human breast cancer cells.
Banti CN; Raptopoulou CP; Psycharis V; Hadjikakou SK
J Inorg Biochem; 2021 Mar; 216():111351. PubMed ID: 33461021
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, Structural, and Cytotoxic Properties of New Water-Soluble Copper(II) Complexes based on 2,9-Dimethyl-1,10-Phenanthroline and Their One Derivative Containing 1,3,5-Triaza-7-Phosphaadamantane-7-Oxide.
Śliwa EI; Śliwińska-Hill U; Bażanów B; Siczek M; Kłak J; Smoleński P
Molecules; 2020 Feb; 25(3):. PubMed ID: 32046362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
